Data / Form D filings / OncoVerity, Inc.
OncoVerity, Inc.: Form D filings
OncoVerity, Inc., a biotechnology company in Aurora, CO, filed 2 Form D notices with the SEC between 2022 and 2024. The latest, on December 10, 2024, reports $14 million sold of a $42 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12635 E Montview Blvd., Aurora, CO, 80045
- Phone
- (720) 859-4105
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1943593
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 10, 2024 | New notice | $42,000,000 | $14,000,000 | $28,000,000 | 2 | Nov 25, 2024 | sec.gov |
| Aug 22, 2022 | New notice | $30,000,000 | $4,000,000 | $26,000,000 | 2 | Jul 26, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Massimiliano Colao | Director, Executive Officer | |
| Arjen Lemmen | Director | |
| Petra Van Vlierberghe | Director | |
| Kimberly Muller | Director | |
| Steven Hess | Director | |
| Clayton Smith | Executive Officer |
Other biotechnology companies in Colorado that filed recently
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
- Shiverbright Technologies, Inc. $200,000 · Aug 7, 2026
Every Form D from the week of Dec 9, 2024 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what OncoVerity, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.